|
Researchers are diligently
trying to find new types of treatment for advanced
prostate cancer and hormone-refractory prostate cancer
(cancer that no longer responds to hormonal therapy). Only
a few of these new treatments that are studied will ever
be approved by the United States Food and Drug
Administration (FDA) and ever make it to market. Others
will fail in clinical trials or will be found to have side
effects that are too toxic.
Ideally new medications that
can cure prostate cancer are needed. Until that time,
research is being conducted to discover medications that
can increase survival times, delay the progression
(spread) of the cancer, help to maintain or improve the
quality of life of patients, and that have tolerable or no
side effects. The most promising research being conducted
is in the area of new, so-called “targeted”
medications. Targeted medications work by attacking or
blocking targets (small proteins or molecules in the body)
that are specifically involved in the growth and spread of
tumor or cancer cells. Medications of this type have
already been developed to treat other common cancers, such
as colon and breast cancer.
Keep up-to-date on all the latest advancements in research and clinical trials through these resources:
|
|
